The U.S. market for oncology imaging is forecast to grow at an 8.2% annual rate to reach over $3.9 billion in 2007, according to a report, U.S. Markets for Diagnostic Oncology Products, issued by market research firm Medtech Insight.
The largest gains are expected in the cancer imaging media segment, due mainly to the anticipated robust expansion in the installed base of PET systems and corresponding strong demand for expensive radiopharmaceuticals, as well as the minimally invasive biopsy products segment, based on continuing strong sales of automated breast biopsy systems, the firm said.
In 2002, noninvasive imaging, in vitro diagnostic modalities, and tissue biopsies were employed in more than 172.5 million U.S. screening and diagnostic oncology procedures, generating more than $2.6 billion in corresponding product sales, according to the Newport Beach, CA-based firm.
By AuntMinnie.com staff writersOctober 7, 2003
Related Reading
Breast-detection market to grow 17% in 2002, November 14, 2002
Copyright © 2003 AuntMinnie.com
